Related Experiment Video
Updated: Jun 4, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Evidence-based practice protocol to improve glucose control in individuals with type 2 diabetes mellitus
1The Pennsylvania State University, Worthington Scranton Campus, Dunmore, PA, USA.
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses
|February 23, 2011
Summary
Adding telephone interventions by advanced practice registered nurses (APRNs) can improve blood glucose control in adults with type 2 diabetes mellitus (TDM). This approach offers a valuable addition to standard diabetes management strategies.
Area of Science:
- Public health
- Endocrinology
- Nursing
Background:
- Type 2 diabetes mellitus (TDM) presents a significant public health challenge in the United States.
- Effective management strategies are crucial for improving glycemic control and patient outcomes.
Purpose of the Study:
- To evaluate the impact of adding telephone interventions by an advanced practice registered nurse (APRN) on blood glucose control in adult patients with TDM.
- To compare the efficacy of this intervention against standard treatment alone.
Main Methods:
- A systematic review and meta-analysis of five randomized controlled trials (RCTs) were conducted.
- The studies focused on adult patients diagnosed with type 2 diabetes mellitus.
Main Results:
- Telephone interventions by APRNs demonstrated a positive effect on blood glucose control.
- This intervention, when added to standard care, showed improvement in glycemic metrics.
Conclusions:
- Telephone-based follow-up by APRNs is a viable strategy to enhance glycemic control in TDM management.
- This intervention can be integrated into existing treatment protocols to improve patient health outcomes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...